These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 22825731

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center.
    Öztaş M, Özgül H, Seyahi E, Uğurlu S.
    Turk J Med Sci; 2022 Aug; 52(4):917-925. PubMed ID: 36326373
    [Abstract] [Full Text] [Related]

  • 29. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988.
    Franzén P, Sutinen S, von Knorring J.
    J Rheumatol; 1992 Feb; 19(2):273-6. PubMed ID: 1629827
    [Abstract] [Full Text] [Related]

  • 30. Diagnosis and management of polymyalgia rheumatica.
    Jones O, Birrell F.
    Practitioner; 2016 Dec; 260(1799):13-6. PubMed ID: 29020715
    [Abstract] [Full Text] [Related]

  • 31. Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
    Manning JE, Harris E, Mathieson H, Sorensen L, Luqmani R, McGettrick HM, Morgan AW, Young SP, Mackie SL.
    J Autoimmun; 2024 Jul; 147():103260. PubMed ID: 38797046
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series.
    Diamantopoulos AP, Hetland H, Myklebust G.
    Biomed Res Int; 2013 Jul; 2013():120638. PubMed ID: 24106691
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Diagnosis and treatment of giant cell arteritis.
    Cantini F, Niccoli L, Nannini C, Bertoni M, Salvarani C.
    Drugs Aging; 2008 Jul; 25(4):281-97. PubMed ID: 18361539
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.
    El Chami S, Springer JM.
    Rheum Dis Clin North Am; 2022 May; 48(2):493-506. PubMed ID: 35400374
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.